Lirequinil

CAS No. 143943-73-1

Lirequinil( —— )

Catalog No. M34317 CAS No. 143943-73-1

Lirequinil (Ro 41-3696) is a small molecule GABAA receptor agonist utilized in the study of neurological disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 380 In Stock
10MG 570 In Stock
25MG 911 In Stock
50MG 1190 In Stock
100MG 1628 In Stock
200MG Get Quote In Stock
500MG 3246 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lirequinil
  • Note
    Research use only, not for human use.
  • Brief Description
    Lirequinil (Ro 41-3696) is a small molecule GABAA receptor agonist utilized in the study of neurological disorders.
  • Description
    Lirequinil (Ro 41-3696) is an orally active partial agonist of the benzodiazepine (BDZ) receptor. Lirequinil has the effect of promoting sleep.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GABA Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    143943-73-1
  • Formula Weight
    448.94
  • Molecular Formula
    C26H25ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=O)(C1=C2C=3C(CCN2C(=O)C(=C1)C4=CC=CC=C4)=CC=C(Cl)C3)N5C[C@@H](OCC)CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. M Tsuboi, et al. Changes in mouse hippocampal EEG characteristics after oral administration of Ro 41-3696, nitrazepam, or zopiclone alone and in combination with ethanol. Pharmacology. 1994 Nov;49(5):278-85. ?
molnova catalog
related products
  • Experimental Autoimm...

    Experimental Autoimmune Encephalomyelitis Complementary Peptide

  • Rofleponide

    Rofleponide is a synthetic glucocorticosteroid with a high affinity for the rat thymus glucocorticoid receptor.

  • BRD-K98645985

    BRD-K98645985 is a BAF (mammalian SWI/SNF) transcriptional repression inhibitor with an EC50 of ~2.37 μM. BRD-K98645985 binds ARID1A-specific BAF complexes, prevents nucleosomal positioning, and potently reverses HIV-1 latency, without T cell activation or toxicity.